Indian tennis star Rohan Bopanna met Lt Governor Manoj Sinha to discuss his initiative to train young tennis talent from Jammu and Kashmir at his Bengaluru academy. Through a collaboration with Kamal ...
Catch all the important highlights that took place on January 27, 2025 in the world of sports featuring the BBL 2024-25 title ...
Rohan Bopanna and Shuai Zhang advanced to the mixed ... focusing on his personal dream of a healthy, happy family. His wife, Elina Svitolina, also advanced with a gritty win.
Indian ace Rohan Bopanna and his Chinese partner Shuai Zhang advanced to the second round of the Australian Open mixed doubles with a commanding 6-4, 6-4 victory over Ivan Dodig and Kristina ...
Melbourne: Indian ace Rohan Bopanna and his Chinese partner Shuai Zhang advanced to the second round of the Australian Open mixed doubles with a straight sets 6-4, 6-4 victory over Ivan Dodig and ...
The mixed doubles pair of Rohan Bopanna and Zhang Shuai cruised into ... India's N Sriram Balaji and his Mexican partner Miguel Angel Reyes-Varela will take on the Portuguese pair of Nuno Borges ...
In an impressive showcase of skill and synergy, Rohan Bopanna and Zhang Shuai ... However, strategic play allowed Bopanna and Shuai to break Mladenovic in the seventh game. Bopanna, drawing on his ...
Melbourne [Australia], January 17 (ANI): The mixed doubles pair of Rohan Bopanna and Zhang Shuai cruised into the second round of the ongoing Australian Open 2025 on Friday as they defeated French ...
IMAGE: Rohan Bopanna showed his mettle alongside Zhang, delivering a clinical performance to close our the match in one hour and 12 minutes. Photograph: Kind Courtesy Rohan Bopanna/Instagram ...
Indian ace Rohan Bopanna and his Chinese partner Shuai Zhang advanced to the second round of the Australian Open mixed doubles with a commanding 6-4, 6-4 victory over Ivan Dodig and Kristina ...
Indian star Rohan Bopanna and Chinese partner Shuai Zhang won against Ivan Dodig and Kristina Mladenovic to advanced to the Australian Open mixed doubles second round. Their clinical performance ...